AMICUS THERAPEUTICS, INC. — Revenue by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5cb5b82e-6f86-4ba2-b23d-460df55487cc/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $634.2M | 2025-01-01 – 2025-12-31 | evidence 0001178879-26-000005 |
| FY 2024 | $528.3M | 2024-01-01 – 2024-12-31 | evidence 0001178879-25-000003 |
| FY 2023 | $399.4M | 2023-01-01 – 2023-12-31 | evidence 0001178879-24-000003 |
| FY 2022 | $329.2M | 2022-01-01 – 2022-12-31 | evidence 0001178879-23-000004 |
| FY 2021 | $305.5M | 2021-01-01 – 2021-12-31 | evidence 0001178879-22-000006 |
| FY 2020 | $260.9M | 2020-01-01 – 2020-12-31 | evidence 0001178879-22-000006 |
| FY 2019 | $182.2M | 2019-01-01 – 2019-12-31 | evidence 0001178879-22-000006 |
| FY 2018 | $91.2M | 2018-01-01 – 2018-12-31 | evidence 0001178879-19-000024 |
| FY 2017 | $36.9M | 2017-01-01 – 2017-12-31 | evidence 0001178879-19-000024 |
| FY 2016 | $5.0M | 2016-01-01 – 2016-12-31 | evidence 0001178879-19-000024 |
| FY 2014 | $1.2M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-001585 |
| FY 2013 | $122.7M | 2002-02-04 – 2014-03-31 | evidence 0001104659-14-034647 |
| FY 2012 | $121.9M | 2002-02-04 – 2013-03-31 | evidence 0001104659-13-039699 |
| FY 2011 | $111.2M | 2002-02-04 – 2012-03-31 | evidence 0001104659-12-036030 |
| FY 2010 | $922.0k | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-085717 |
| FY 2009 | $64.4M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-085717 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AMICUS THERAPEUTICS, INC. — all facts · Net Income · Operating Income